Robert Bernard Stockman

Robert Bernard Stockman discloses dealings in 2 companies, chiefly REVA Medical, Inc. and HeartWare International, Inc. The record holds 13 filings, for trades running from 29 March 2016 to 11 November 2019.

Purchases make up the whole of the open-market record (5 purchases, €272k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants and 3 option exercises. 2019 to date brings 1 purchase and no sales.

The median purchase comes to €44k. 3 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 14 November 2019, the filings show an open-market purchase worth €101 in REVA Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.